Italia - italiano - Ministero della Salute

acef spa -

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

ebi-pharm ag - ubichinonum d10 (hab 5a), acidum ascorbicum d6 (hab 5a), thiaminum hydrochloricum d6 (hab 5a), natrium riboflavinum phosphoricum d6 (hab 5a), pyridoxinum hydrochloricum d6 (hab 5a), nicotinamidum d6 (hab 5a), vaccinium myrtillus (hab) d6, colchicum autumnale (hab) d6, podophyllum peltatum (hab) d6, hydrastis canadensis (ph.eur.hom.) d6 (ph.eur.hom. 1.1.8), acidum l(+) lacticum d6 (hab 5a), hydrochinonum d8 (hab 5a), acidum thiocticum d8 (hab 6), sulfur (hab) d8, manganum phosphoricum d8 (hab 6), natrium diethyloxalaceticum d8 (hab 6), trichinoylum d10 (hab 6), anthrachinonum d10 (hab 6), naphthochinonum d10 (hab 5a), para-benzochinonum d10 (hab 5a), adenosinum triphosphoricum d10 (hab 5a), coenzym a d10 (hab 5a), galium aparine (hab) d6, acidum acetylsalicylicum d10 (hab 5a), histaminum d10 (hab 5a), nadidum d10 (hab 5a), magnesium gluconicum d10 (hab 5a) - compresse - ubichinonum d10 (hab, 5a) 1.0 mg, acido ascorbicum d6 (hab, 5a) 1.0 mg, thiaminum hydrochloricum d6 (hab, 5a) 1.0 mg, sodio riboflavinum phosphoricum d6 (hab, 5a) 1.0 mg, pyridoxinum hydrochloricum d6 (hab, 5a) 1.0 mg, nicotinamidum d6 (hab, 5a) 1.0 mg, mirtillo myrtillus (hab) d6 1.0 mg, colchicum autumnale (hab) d6 1.0 mg, podophyllum peltatum (hab) d6 1.0 mg, hydrastis canadensis extract canadese (ph. eur.hom.) d6 (ph. eur.hom. 1.1.8) 1.0 mg, acido l(+) lacticum d6 (hab, 5a) 1.0 mg, hydrochinonum d8 (hab, 5a) 1.0 mg, acido thiocticum d8 (hab 6) 1.0 mg), zolfo (hab) d8 1.0 mg, manganum phosphoricum d8 (hab 6) 1.0 mg, sodio diethyloxalaceticum d8 (hab 6) 1.0 mg, trichinoylum d10 (hab 6) 1.0 mg, anthrachinonum d10 (hab 6) 1.0 mg, naphthochinonum d10 (hab, 5a) 1.0 mg, para-benzochinonum d10 (hab, 5a) 1.0 mg, adenosinum triphosphoricum d10 (hab, 5a) 1.0 mg, coenzymum un d10 (hab, 5a) 1.0 mg, è stato aparine (hab) d6 1.0 mg, acido acetylsalicylicum d10 (hab, 5a) 1.0 mg, histaminum d10 (hab, 5a) 1.0 mg nadidum d10 (hab, 5a) 1.0 mg, magnesio gluconicum d10 (hab, 5a) 1.0 mg excipiens excipiens lactosum monohydricum, magnesio stearas, per compresso corrisp. lactosum monohydricum 300 mg, lactosum monohydricum 300.0 mg. - senza indicazione - farmaci omeopatici

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

ebi-pharm ag - acido alfa-ketoglutaricum d8 (hab, 5a), acido malicum d8 (hab, 5a), acido fumaricum d8 (hab, 5a), acido l(+) lacticum d3 (hab, 5a), adenosinum triphosphoricum d8 (hab, 5a), calcium fluoratum (hab) d10, colchicum autumnale (hab) d4, conium impure (hab) d4, cortisonum aceticum d28 (hab, 6), euspongia officinalis (hab) d8, drone vesiculosus (hab) d6, cavo umbilicalis loro d10 (hab, 42a), era aparine (hab) d4, ghiandole thyreoidea loro d8 (hab, 42a), il loro fegato d10 (hab 42 bis), del midollo ossis loro d10 (hab, 42a), sodio diethyloxalaceticum d8 (hab, 6), pulsatilla pratensis (hab) d8, sedum acre (hab) d6, sempervivum tv var. edifici (hab) d6, splen loro d10 (hab, 42a), zolfo (hab) d10, timo loro d10 (hab, 42a), viscum album (hab) d3 - soluzione iniettabile (s. c. i. c. i. m.) - acido alfa-ketoglutaricum d8 (hab, 5a) 22.0 mg, acido malicum d8 (hab, 5a) 22.0 mg, acido fumaricum d8 (hab, 5a) 22.0 mg, acido l(+) lacticum d3 (hab, 5a) 22.0 mg, adenosinum triphosphoricum d8 (hab, 5a) 22.0 mg, calcium fluoratum (hab) d10 22.0 mg, colchicum autumnale (hab) d4 22.0 mg, conium impure (hab) d4 22.0 mg, cortisonum aceticum d28 (hab 6) 22.0 mg, euspongia officinalis (hab) d8 22.0 mg, drone vesiculosus (hab) d6 22.0 mg, cavo umbilicalis loro d10 (hab, 42a) 22.0 mg, ed è stato aparine (hab) d4 22.0 mg, ghiandole thyreoidea loro d8 (hab, 42a) 22.0 mg, il fegato per loro d10 (hab, 42a) 22.0 mg, midollo ossis loro d10 (hab, 42a) 22.0 mg, sodio diethyloxalaceticum d8 (hab 6) 22.0 mg, pulsatilla pratensis (hab) d8 22.0 mg, sedum acre (hab) d6 22.0 mg, sempervivum tv var. edifici (hab) d6 22.0 mg, splen loro d10 (hab, 42a) 22.0 mg), zolfo (hab) d10 22.0 mg, timo loro d10 (hab, 42a) 22.0 mg, viscum album (hab) d3 22.0 mg, excipiens natrii chloridum, aqua ad iniectabilia, per il vetro 2.2 g corrisp. sodio 7.64 mg. - senza indicazione - farmaci omeopatici

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

ebi-pharm ag - ubichinonum d10 (hab 5a), acidum ascorbicum d6 (hab 5a), thiaminum hydrochloricum d6 (hab 5a), natrium riboflavinum phosphoricum d6 (hab 5a), pyridoxinum hydrochloricum d6 (hab 5a), nicotinamidum d6 (hab 5a), vaccinium myrtillus (hab) d4, colchicum autumnale (hab) d4, podophyllum peltatum (hab) d4, conium maculatum (hab) d4, hydrastis canadensis (ph.eur.hom.) d4 (ph.eur.hom. 1.1.8), acidum l(+) lacticum d6 (hab 5a), hydrochinonum d8 (hab 5a), acidum thiocticum d8 (hab 6), sulfur (hab) d8, manganum phosphoricum d8 (hab 6), natrium diethyloxalaceticum d8 (hab 6), trichinoylum d10 (hab 6), anthrachinonum d10 (hab 6), naphthochinonum d10 (hab 5a), para-benzochinonum d10 (hab 5a), adenosinum triphosphoricum d10 (hab 5a), coenzym a d10 (hab 5a), galium aparine (hab) d6, acidum acetylsalicylicum d10 (hab 5a), histaminum d10 (hab 5a), nadidum d10 (hab 5a), magnesium gluconicum d10 (hab 5a) - soluzione iniettabile (s. c. i. m.) - ubichinonum d10 (hab 5a) 22 mg, acidum ascorbicum d6 (hab 5a) 22 mg, thiaminum hydrochloricum d6 (hab 5a) 22 mg, natrium riboflavinum phosphoricum d6 (hab 5a) 22 mg, pyridoxinum hydrochloricum d6 (hab 5a) 22 mg, nicotinamidum d6 (hab 5a) 22 mg, vaccinium myrtillus (hab) d4 22 mg, colchicum autumnale (hab) d4 22 mg, podophyllum peltatum (hab) d4 22 mg, conium maculatum (hab) d4 22 mg, hydrastis canadensis (ph.eur.hom.) d4 (ph.eur.hom. 1.1.8) 22 mg, acidum l(+) lacticum d6 (hab 5a) 22 mg, hydrochinonum d8 (hab 5a) 22 mg, acidum thiocticum d8 (hab 6) 22 mg, sulfur (hab) d8 22 mg, manganum phosphoricum d8 (hab 6) 22 mg, natrium diethyloxalaceticum d8 (hab 6) 22 mg, trichinoylum d10 (hab 6) 22 mg, anthrachinonum d10 (hab 6) 22 mg, naphthochinonum d10 (hab 5a) 22 mg, para-benzochinonum d10 (hab 5a) 22 mg, adenosinum triphosphoricum d10 (hab 5a) 22 mg, coenzymum a d10 (hab 5a) 22 mg, galium aparine (hab) d6 22 mg, acidum acetylsalicylicum d10 (hab 5a) 22 mg, histaminum d10 (hab 5a) 22 mg, nadidum d10 (hab 5a) 22 mg, magnesium gluconicum d10 (hab 5a) 22 mg, aqua ad iniectabilia, natrii chloridum corresp. natrium 7.51 mg, pro vitro 2.2 ml. - senza indicazione - farmaci omeopatici

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

ebi-pharm ag - coenzym a d8 (hab 5a), acidum ascorbicum d6 (hab 5a), thiaminum hydrochloricum d6 (hab 5a), natrium riboflavinum phosphoricum d6 (hab 5a), pyridoxinum hydrochloricum d6 (hab 5a), nicotinamidum d6 (hab 5a), acidum malicum d8 (hab 5a), acidum cis-aconiticum d8 (hab 5a), acidum citricum (hab) d8, acidum fumaricum d8 (hab 5a), acidum alpha-ketoglutaricum d8 (hab 5a), acidum succinicum (ph. eur. hom.) d8 (hab 5a), barium oxalsuccinicum d10 (hab 6), natrium diethyloxalaceticum d6 (hab 6), natrium pyruvicum d8 (hab 5a), cysteinum d6 (hab 5a), pulsatilla pratensis (hab) d6, hepar sulfuris (hab) d10, sulfur (hab) d10, adenosinum triphosphoricum d10 (hab 5a), nadidum d8 (hab 5a), manganum phosphoricum d6 (hab 6), magnesium oroticum dihydricum d6 (hab 6), cerium oxalicum (hab) d8, acidum thiocticum d6 (hab 6), beta vulgaris rubra ex radice d6 (hab 2a) - compresse - coenzymum un d8 (hab, 5a) 1.0 mg, acido ascorbicum d6 (hab, 5a) 1.0 mg, thiaminum hydrochloricum d6 (hab, 5a) 1.0 mg, sodio riboflavinum phosphoricum d6 (hab, 5a) 1.0 mg, pyridoxinum hydrochloricum d6 (hab, 5a) 1.0 mg, nicotinamidum d6 (hab, 5a) 1.0 mg, acido malicum d8 (hab, 5a) 1.0 mg, acido cia-aconiticum d8 (hab, 5a) 1.0 mg, acido citricum (hab) d8 1.0 mg, acido fumaricum d8 (hab, 5a) 1.0 mg, acido alfa-ketoglutaricum d8 (hab, 5a) 1.0 mg, acido succinicum (ph. eur. hom.) d8 (hab, 5a) 1.0 mg, bario oxalsuccinicum d10 (hab 6) 1.0 mg, sodio diethyloxalaceticum d6 (hab 6) 1.0 mg, sodio pyruvicum d8 (hab, 5a) 1.0 mg, cysteinum d6 (hab, 5a) 1.0 mg, pulsatilla pratensis (hab) d6 1.0 mg, il fegato sulfuris (hab) d10 1.0 mg), zolfo (hab) d10 1.0 mg, adenosinum triphosphoricum d10 (hab, 5a) 1.0 mg nadidum d8 (hab, 5a) 1.0 mg, manganum phosphoricum d6 (hab 6) 1.0 mg, magnesio oroticum dihydricum d6 (hab 6) 1.0 mg, cerio oxalicum (hab) d8 1.0 mg, acido thiocticum d6 (hab 6) 1.0 mg, beta comuni e rossi dalla radice di d6 (hab 2a) 1.0 mg, lactosum monohydricum, magnesio stearas, per compresso corrisp. lactosum monohydricum 300 mg. - senza indicazione - farmaci omeopatici

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

ebi-pharm ag - acidum alpha-ketoglutaricum d8 (hab 5a), acidum thiocticum d6 (hab 6), acidum ascorbicum d6 (hab 5a), acidum cis-aconiticum d8 (hab 5a), acidum citricum (hab) d8, acidum malicum d8 (hab 5a), acidum fumaricum d8 (hab 5a), acidum succinicum (ph. eur. hom.) d8 (hab 5a), adenosinum triphosphoricum d10 (hab 5a), barium oxalsuccinicum d10 (hab 6), beta vulgaris rubra ex radice d4 (hab 2a), cerium oxalicum (hab) d8, coenzym a d8 (hab 5a), cysteinum d6 (hab 5a), hepar sulfuris (hab) d10, magnesium oroticum dihydricum d6 (hab 6), manganum phosphoricum d6 (hab 6), nadidum d8 (hab 5a), natrium diethyloxalaceticum d6 (hab 6), natrium pyruvicum d8 (hab 5a), natrium riboflavinum phosphoricum d6 (hab 5a), nicotinamidum d6 (hab 5a), pulsatilla pratensis (hab) d6, pyridoxinum hydrochloricum d6 (hab 5a), sulfur (hab) d10 (hab sv), thiaminum hydrochloricum d6 (hab 5a) - soluzione iniettabile (s. c. i. m.) - acidum alpha-ketoglutaricum d8 (hab 5a) 22 mg, acidum thiocticum d6 (hab 6) 22 mg, acidum ascorbicum d6 (hab 5a) 22 mg, acidum cis-aconiticum d8 (hab 5a) 22 mg, acidum citricum (hab) d8 22 mg, acidum malicum d8 (hab 5a) 22 mg, acidum fumaricum d8 (hab 5a) 22 mg, acidum succinicum (ph. eur. hom.) d8 (hab 5a) 22 mg, adenosinum triphosphoricum d10 (hab 5a) 22 mg, barium oxalsuccinicum d10 (hab 6) 22 mg, beta vulgaris rubra ex radice d4 (hab 2a) 22 mg, cerium oxalicum (hab) d8 22 mg, coenzymum a d8 (hab 5a) 22 mg, cysteinum d6 (hab 5a) 22 mg, hepar sulfuris (hab) d10 22 mg, magnesium oroticum dihydricum d6 (hab 6) 22 mg, manganum phosphoricum d6 (hab 6) 22 mg, nadidum d8 (hab 5a) 22 mg, natrium diethyloxalaceticum d6 (hab 6) 22 mg, natrium pyruvicum d8 (hab 5a) 22 mg, natrium riboflavinum phosphoricum d6 (hab 5a) 22 mg, nicotinamidum d6 (hab 5a) 22 mg, pulsatilla pratensis (hab) d6 22 mg, pyridoxinum hydrochloricum d6 (hab 5a) 22 mg, sulfur (hab) d10 (hab sv) 22 mg, thiaminum hydrochloricum d6 (hab 5a) 22 mg, aqua ad iniectabile, natrii chloridum corresp. natrium 7.6 mg, ad solutionem pro 2.2 ml. - senza indicazione - farmaci omeopatici

Unione Europea - italiano - EMA (European Medicines Agency)

glaxosmithkline trading services - mepolizumab - asma - farmaci per le malattie respiratorie ostruttive, - severe eosinophilic asthmanucala is indicated as an add-on treatment for severe refractory eosinophilic asthma in adults, adolescents and children aged 6 years and older. chronic rhinosinusitis with nasal polyps (crswnp)nucala is indicated as an add-on therapy with intranasal corticosteroids for the treatment of adult patients with severe crswnp for whom therapy with systemic corticosteroids and/or surgery do not provide adequate control. eosinophilic granulomatosis with polyangiitis (egpa)nucala is indicated as an add-on treatment for patients aged 6 years and older with relapsing-remitting or refractory eosinophilic granulomatosis with polyangiitis (egpa). hypereosinophilic syndrome (hes)nucala is indicated as an add-on treatment for adult patients with inadequately controlled hypereosinophilic syndrome without an identifiable non-haematologic secondary cause.

Unione Europea - italiano - EMA (European Medicines Agency)

novartis europharm limited - omalizumab - asthma; urticaria - farmaci per le malattie respiratorie ostruttive, - allergica asthmaxolair è indicato negli adulti, negli adolescenti e bambini (da 6 a.

Unione Europea - italiano - EMA (European Medicines Agency)

sanofi winthrop industrie - dupilumab - dermatitis, atopic; prurigo; esophageal diseases; asthma; sinusitis - agenti per dermatiti, esclusi i corticosteroidi - atopic dermatitisadults and adolescentsdupixent is indicated for the treatment of moderate-to-severe atopic dermatitis in adults and adolescents 12 years and older who are candidates for systemic therapy. children 6 months to 11 years of agedupixent is indicated for the treatment of severe atopic dermatitis in children 6 months to 11 years old who are candidates for systemic therapy. asthmaadults and adolescentsdupixent is indicated in adults and adolescents 12 years and older as add-on maintenance treatment for severe asthma with type 2 inflammation characterised by raised blood eosinophils and/or raised fraction of exhaled nitric oxide (feno), see section 5. 1, who are inadequately controlled with high dose inhaled corticosteroids (ics) plus another medicinal product for maintenance treatment. children 6 to 11 years of agedupixent is indicated in children 6 to 11 years old as add-on maintenance treatment for severe asthma with type 2 inflammation characterised by raised blood eosinophils and/or raised fraction of exhaled nitric oxide (feno), who are inadequately controlled with medium to high dose inhaled corticosteroids (ics) plus another medicinal product for maintenance treatment. chronic rhinosinusitis with nasal polyposis (crswnp)dupixent is indicated as an add-on therapy with intranasal corticosteroids for the treatment of adults with severe crswnp for whom therapy with systemic corticosteroids and/or surgery do not provide adequate disease control. prurigo nodularis (pn)dupixent is indicated for the treatment of adults with moderate-to-severe prurigo nodularis (pn) who are candidates for systemic therapy. eosinophilic esophagitis (eoe)dupixent is indicated for the treatment of eosinophilic esophagitis in adults and adolescents 12 years and older, weighing at least 40 kg, who are inadequately controlled by, are intolerant to, or who are not candidates for conventional medicinal therapy.

Italia - italiano - AIFA (Agenzia Italiana del Farmaco)

boehringer ingelheim italia s.p.a. - associazioni - associazioni